--- title: "FDA’s Latest Import Alert on Nicotine Pouches: What It Means for Manufacturers" description: "Discover what FDA Import Alert #98-06 means for nicotine pouch manufacturers. Stay compliant with expert PMTA support from Broughton. Learn more today" image: https://www.broughton-group.com/hubfs/Picture1fda.jpg --- # FDA’s Latest Import Alert on Nicotine Pouches: What It Means for Manufacturers ### Nicotine ![](https://www.broughton-group.com/hubfs/Picture1fda.jpg) Feb 25, 2025 | Published by  [ Chris Allen ](https://www.broughton-group.com/blog/author/chris-allen) Nicotine The nicotine pouch market in the US is growing rapidly, but so is regulatory scrutiny. The FDA’s latest import alert [(#98-06)](https://www.accessdata.fda.gov/cms_ia/importalert_1163.html) illustrates one thing clearly: products without the required marketing authorisation risk detention at the border without physical examination.  For manufacturers looking to enter or expand in the US market, compliance is not optional.  **Regulatory Challenges: Turning Hurdles into Opportunities**  To market a new tobacco product in the US, you must follow one of the three paths:  1. Premarket Tobacco Product Applications (PMTA)  1. Substantial Equivalence (SE) Reports  1. Exemption from Substantial Equivalence Requests (EX REQ)  The only pathway via which a new applicant can market a nicotine pouch in the US, is via the PMTA. The FDA requires a Premarket Tobacco Product Application (PMTA) for all new nicotine pouches. Without a PMTA, products may be considered adulterated and misbranded, leading to detentions, import refusals, and market exclusion.  But with challenge comes opportunity.   The brands that succeed will be those that embrace scientific substantiation and take proactive steps toward compliance. A well-prepared PMTA isn’t just a regulatory requirement, it is the foundation for long-term market success.  **Navigating Compliance with Broughton**  At Broughton, we support companies in navigating the US regulatory landscape with confidence. From toxicology and analytical testing to submission strategy and engagement with the FDA, we provide end-to-end PMTA support.  Want to ensure your nicotine pouch products remain compliant and stay on the market? [Contact our team today.](https://www.broughton-group.com/contact)  ### Sign up to our newsletter Ensure your business stays ahead of the competition by keeping up to date with the latest industry news. Sign-up for our newsletter to have the latest information and insights served directly to your inbox. ### Related posts [View all](https://www.broughton-group.com/blog/) [![](https://www.broughton-group.com/hs-fs/hubfs/iStock-1419279405-3.jpg?height=200&name=iStock-1419279405-3.jpg) ](https://www.broughton-group.com/blog/navigating-the-fdas-evolving-guidelines-on-genotoxicity-and-elcr-in-pmta-submissions) [**Toxicology**](https://www.broughton-group.com/blog/tag/toxicology) 1 minute read ### [Navigating the FDA’s Evolving Guidelines on Genotoxicity and ELCR in PMTA Submissions](https://www.broughton-group.com/blog/navigating-the-fdas-evolving-guidelines-on-genotoxicity-and-elcr-in-pmta-submissions) The regulatory landscape surrounding Premarket Tobacco Product Applications (PMTAs) is continuously evolving, with recent updates from the FDA prompting significant changes in how applicants should... [![](https://www.broughton-group.com/hubfs/1761665220999.jfif) ](https://www.broughton-group.com/blog/fdas-acknowledgement-of-harm-reduction-marks-a-turning-point-at-fdli-2025) [**Nicotine**](https://www.broughton-group.com/blog/tag/nicotine) 1 minute read ### [FDA’s Acknowledgement of Harm Reduction Marks a Turning Point at FDLI 2025](https://www.broughton-group.com/blog/fdas-acknowledgement-of-harm-reduction-marks-a-turning-point-at-fdli-2025) The 2025 Food and Drug Law Institute (FDLI) Tobacco and Nicotine Conference delivered something the industry has been waiting for: a visible and vocal presence from the FDA’s Center for Tobacco... [![](https://www.broughton-group.com/hs-fs/hubfs/unnamed_161eaec4-2e8a-4c7e-a890-6169386754e2.jpg?height=200&name=unnamed_161eaec4-2e8a-4c7e-a890-6169386754e2.jpg) ](https://www.broughton-group.com/blog/the-fdas-authorisation-of-zyn-a-robust-pmta-in-a-changing-landscape) [**Nicotine**](https://www.broughton-group.com/blog/tag/nicotine) 1 minute read ### [The FDA’s Authorisation of Zyn: A Robust PMTA in a Changing Landscape](https://www.broughton-group.com/blog/the-fdas-authorisation-of-zyn-a-robust-pmta-in-a-changing-landscape) On January 16, 2025, the FDA granted marketing authorisation for Swedish Match’s Zyn nicotine pouches, marking a significant regulatory milestone for the modern oral nicotine market. Given the rapid...